Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal research …, 2019 - Wiley Online Library
Microtubule (MT)‐targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal Research …, 2019 - europepmc.org
Microtubule (MT)-targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal Research …, 2019 - search.ebscohost.com
Microtubule (MT)‐targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal Research …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Microtubule (MT)‐targeting agents are highly
successful drugs as chemotherapeutic agents, and this is attributed to their ability to target …

[HTML][HTML] Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen, S Deng… - Medicinal research …, 2019 - ncbi.nlm.nih.gov
Microtubule (MT)-targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

[PDF][PDF] Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen, S Deng, DJ Hwang… - researchgate.net
Microtubule (MT)‐targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

KE Arnst, S Banerjee, H Chen… - Medicinal research …, 2019 - pubmed.ncbi.nlm.nih.gov
Microtubule (MT)-targeting agents are highly successful drugs as chemotherapeutic agents,
and this is attributed to their ability to target MT dynamics and interfere with critical cellular …